The Wall Street Journal reports that Roche has adopted a strategy that focuses on marketing drugs for the treatment of cancer, AIDS and transplantation rather than competing for a share of mass-market pills. The strategy includes forging numerous partnerships with biotech companies that will assume responsibility for research.

Related Summaries